National Health Investors (NYSE:NHI) Price Target Raised to $92.00 at Truist Financial

National Health Investors (NYSE:NHI) had its price objective increased by Truist Financial from $85.00 to $92.00 in a research report report published on Thursday morning,Benzinga reports. The firm currently has a buy rating on the real estate investment trust’s stock.

A number of other research firms have also weighed in on NHI. National Bank Financial set a $85.00 target price on National Health Investors in a research note on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 price objective on shares of National Health Investors in a report on Monday, January 5th. KeyCorp raised their target price on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Wells Fargo & Company lifted their price target on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $86.86.

National Health Investors Stock Performance

National Health Investors stock opened at $85.36 on Thursday. The firm’s fifty day moving average price is $83.27 and its 200-day moving average price is $79.32. National Health Investors has a fifty-two week low of $66.41 and a fifty-two week high of $91.38. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The stock has a market cap of $4.13 billion, a P/E ratio of 28.26, a price-to-earnings-growth ratio of 4.57 and a beta of 0.65.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The firm had revenue of $105.82 million for the quarter, compared to the consensus estimate of $95.12 million. During the same period last year, the firm earned $1.24 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, equities research analysts expect that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Tuesday, March 31st will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 4.3%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s dividend payout ratio (DPR) is presently 121.85%.

Institutional Investors Weigh In On National Health Investors

Hedge funds have recently modified their holdings of the business. International Assets Investment Management LLC bought a new position in shares of National Health Investors during the 4th quarter valued at approximately $27,000. EverSource Wealth Advisors LLC grew its stake in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in shares of National Health Investors during the fourth quarter valued at about $33,000. GAMMA Investing LLC grew its holdings in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 136 shares in the last quarter. Finally, Key Capital Management INC bought a new stake in National Health Investors in the fourth quarter worth $47,000. Institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.